Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-07-15

Clinical Trial Update: Periperal Blood Lymphocytes During Prostate RT

View source ↗

Summary

A clinical trial investigating peripheral blood lymphocytes during prostate radiotherapy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Health Network, Toronto | Conditions: Prostate Cancer | Status: WITHDRAWN